Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Quincy › NPI 1831534205
Physician

Luo, Lily

Luo, Lily was paid $590K by Medicaid between Jan 2018 and Mar 2023, across 37 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.

33Billing provider infoLUO, LILY
QUINCY, MA 02171
33aNPI1831534205assigned 04/30/2013
33bProvider typePediatrics Physician
28Total paid$590K
24GClaims13,894
24DCodes billed37
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers

Next to other Pediatrics Physician providers in Massachusetts

Rank by total paid#135 of 1,273
Median peer was paid$24K
This provider vs. median25×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,586$70K
20192,242$94K
20202,426$96K
20213,248$140K
20223,755$161K
2023637$29K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 39% 4,021 3,321 $230K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 34% 2,052 1,751 $202K
90460 Immunization administration through 18 years of age via any route, first or only component 7.4% 1,572 1,417 $44K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 2.3% 1,487 1,474 $14K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.2% 550 510 $13K
99051 1.8% 626 573 $10K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.5% 105 105 $9K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.4% 822 765 $8K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.3% 95 95 $8K
99173 1.3% 351 350 $8K
99401 <1% 194 191 $6K
96127 <1% 515 515 $5K
25 more codes
0071A <1% 91 $4K
0072A <1% 81 $4K
92552 <1% 105 $3K
0074A <1% 57 $3K
90461 <1% 65 $2K
99188 <1% 75 $2K
36416 <1% 191 $2K
99442 <1% 88 $2K
0082A <1% 35 $2K
0083A <1% 33 $2K
0124A <1% 25 $1K
0081A <1% 23 $1K
0002A <1% 23 $1K
0004A <1% 18 $825.84
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 60 $800.16
0054A <1% 12 $750.00
0001A <1% 15 $688.20
0154A <1% 12 $550.56
99177 <1% 12 $450.00
85018 <1% 188 $423.16
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 15 $305.20
99000 <1% 242 $242.00
94664 <1% 12 $172.56
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 14 $115.00
92551 <1% 12 $101.16

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.